Articles from Chimerix, Inc.; Jazz Pharmaceuticals plc

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tumors-

By Chimerix, Inc.; Jazz Pharmaceuticals plc · Via GlobeNewswire · March 5, 2025